1. Home
  2. LEE vs ITRM Comparison

LEE vs ITRM Comparison

Compare LEE & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lee Enterprises Incorporated

LEE

Lee Enterprises Incorporated

HOLD

Current Price

$3.57

Market Cap

22.9M

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.41

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEE
ITRM
Founded
1890
2015
Country
United States
Ireland
Employees
2500
N/A
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.9M
24.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
LEE
ITRM
Price
$3.57
$0.41
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
17.5K
1.2M
Earning Date
11-26-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$562,341,000.00
$390,000.00
Revenue This Year
$5.48
N/A
Revenue Next Year
N/A
$325.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.70
$0.36
52 Week High
$16.84
$2.18

Technical Indicators

Market Signals
Indicator
LEE
ITRM
Relative Strength Index (RSI) 34.55 36.53
Support Level $3.90 $0.44
Resistance Level $4.43 $0.49
Average True Range (ATR) 0.38 0.04
MACD -0.04 0.01
Stochastic Oscillator 0.00 1.35

Price Performance

Historical Comparison
LEE
ITRM

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: